This posting is no longer listed by Synolotx.
hirly last saw it live on 1 September 2026. Similar roles are on the live board.
Synolotx
General Opportunity
Cambridge, MA
Apply through hirly
hirly scores this role against your resume, shows its reasoning, then writes a resume and cover letter for it and fills the application with you. Free to start — no card required.
hirly's read of this role
- Seniority
- Mid level
- Country
- US
- Work mode
- On-site / unstated
- First seen by hirly
- 1 Sept 2026
Derived automatically from the posting. Sign up to see how the role scores against your own resume.
the posting
About Synolo Therapeutics:
Synolo Therapeutics, an early-stage biotechnology company launched by RA Ventures, is pioneering the development of precision-targeted immunotherapies for cancer. Powered by computational protein design and proprietary technologies that yield biological data sets at unprecedented scale and resolution, we are building a pipeline of first-in-class multi-specific biologics with novel functionalities. Synolo was founded by pioneers in the field of protein design and engineering, synthetic biology, DNA sequencing, immunology, and biologics drug discovery and development.
About RA Capital:
RA Capital Management funds and builds healthcare and life science companies using an evidence-based investment approach informed by TechAtlas, a think tank within RA Capital which analyzes scientific and clinical data from academic literature and industry sources to anticipate how breakthroughs might impact industry stakeholders, physicians, patients, and policymakers. TechAtlas' analyses are captured in a unique collection of competitive landscapes, or ‘maps’, that identify competitive therapeutics, diagnostics, research tools, and/or technological capabilities in a given area.
Is this role actually a fit for you?
hirly answers with a score and its reasoning, then writes the resume and cover letter if you decide to go for it.
Score it against my resume